Semax
ACTH (4-10) analogue, Heptapeptide
A Russian nootropic peptide approved in Russia for stroke and cognitive disorders, and essentially unstudied everywhere else.
Preclinical only
Registered in Russia and some former Soviet states for stroke, transient ischaemic attack and cognitive disorders. Never submitted to the FDA or EMA, and not approved in any Western jurisdiction.
What it is
Semax is a seven amino acid peptide derived from ACTH fragment 4-10, modified to resist breakdown. Stripped of the hormonal activity of the parent molecule, what remains is neurological: reported effects on BDNF expression, on dopaminergic and serotonergic signalling, and on neuroprotection after ischaemia.
The evidence problem is geographic
Semax has been used clinically in Russia since the 1990s and is on the Russian list of essential medicines. There is a real body of clinical literature behind that.
There is also almost nothing outside it. The trials are largely Russian-language, frequently pre-date modern reporting standards, and have not been replicated by independent groups in Europe or the United States. No Western regulator has evaluated it, because nobody has asked one to.
This puts it in an awkward category. Dismissing it as unstudied is not accurate, since studies exist. Treating it as validated is also not accurate, since the studies have not survived independent scrutiny. The honest position is that a drug approved in one country and ignored in every other usually means something, and here that something is unresolved.
What it is actually approved for
In Russia: acute ischaemic stroke, transient ischaemic attack, and cognitive disorders following brain injury. Clinical settings, in patients with identifiable neurological damage.
The common use elsewhere is cognitive enhancement in healthy adults, which is not the same thing. As with the growth hormone secretagogues, a drug that helps a damaged system does not necessarily improve a functioning one, and there is no trial base for the second claim.
Practical notes
- Intranasal is the usual route and the one Russian protocols use, on the theory of more direct access to the central nervous system.
- Short courses, not continuous use. The clinical protocols are time-limited and community practice follows that, though nobody has established what continuous use would do.
- Take it early. The stimulating effect interferes with sleep for a lot of people if taken in the afternoon.
- N-Acetyl Semax and its amidate variants are sold as improved versions. The modifications are real; the comparative evidence that they work better is not.
Side effects and warning signs
Commonly reported
- Nasal irritation with the intranasal route
- Occasional headache
- Overstimulation or difficulty sleeping if taken late in the day
- No systematic Western safety dataset exists
Stop and get medical help
- Marked mood change or agitation, since this acts on melanocortin and BDNF signalling in the brain
- Any new neurological symptom
Sources
From the community
Discussion for this compound concentrates in r/Biohackers and r/Peptidesource.
No threads cached yet.
Reddit removed unauthenticated API access, so this section is populated by a build-time script using your own API credentials. Run pnpm fetch:reddit with REDDIT_CLIENT_ID and REDDIT_CLIENT_SECRET set.